PRESS RELEASES ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 2 years ago
PRESS RELEASES Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody 2 years ago
General Cambodia Calls for Development Partners’ Continued Commitment to Achieve 2025 Mine-free Vision 2 years ago
